FindTrial
Sign In

A Clinical Trial Of Tilashelukaravi Syrup And Yoga In The Management Of Polycystic Ovarian Disease

Role Of Tilashelukaravi Syrup And Selective Yoga Therapies In The Management Of Kshina Artava With Special Reference To Polycystic Ovarian Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039419
Enrollment
60
Registered
2022-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

None listed

Sponsors

ABDUL ALIM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Bleeding Or Spotting Less Than 2 Days. 2.Infrequent Menses At Interval Longer Than 35 Days Or Scanty. 3.With Minimum 3 Cycles Of History Of Oligomenorrhoea Or Hypomenorrhoea. 4.Irrespective Of Gravida Both Married And Unmarried Women Of Age 16 Years To 45 Years. 5.Confirmatory Findings On USG

Exclusion criteria

Exclusion criteria: 1.Patients Having Physiological Infrequent Menstruation. 2.Pregnant Women. 3.Lactating Mothers. 4.Women Taking Ocps. 5.Patients Suffering From Any Systemic Diseases. 6.Patients Having Any Organic Pathology Of Uterus And Adnexa. 7.Patients With Hb Level Less Than 7 Gm/Dl.

Design outcomes

Primary

MeasureTime frame
Decrease In Symptoms Of Kshina Artava (Pcod) Like 1.Normalise The Interval Between Two Cycles. 2.To Normalise The Amount Of Blood Loss. 3.To Normalise The Duration Of Bleeding. 4.Minimise The Grade Of Pain. Timepoint: 60 Days—

Secondary

MeasureTime frame
1.USG REPORT TO BE WITHIN NORMAL LIMITS. 2.SERUM PROLACTIN 3.AMH 4.TSH,T3,T4 HB 5.HB% Timepoint: 60 DAYS—

Countries

India

Contacts

Public ContactProf Dr Yanbeni Humtsoe

Govt. Ayurvedic College & Hospital

pybeni17@gmail.com8638807437

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026